A winning approach to biotech

Horizon 3 Biotech is an AU$100m venture capital fund investing to improve lives globally through investments in public and private later-stage companies targeting a return of more than 20% IRR per annum. 

Our ‘Achilles Heel’ approach limits the downside and increases the upside through rigorous due diligence and instinct. We preserve capital by investing in later opportunities closer to exit. 

Biotech is booming and outperforms. If you are looking to diversify your portfolio and achieve outstanding returns in one of the world's highest growth areas, visit our website for more information.